Agarose microspheres are gaining widespread adoption in both biomedical and cosmetic sectors due to their high hydrophilicity, uniform porosity, low immunogenicity, and excellent matrix tunability. BOC Sciences offers customized small- and large-scale manufacturing services for agarose microspheres, optimized for diverse applications such as affinity chromatography, cell encapsulation, sustained drug release, and injectable aesthetic formulations. Leveraging our advanced hydrogel engineering capabilities, we utilize proprietary emulsification, crosslinking, and template-assisted methods to precisely control particle size, morphology, and surface functionality. All production batches undergo rigorous quality control for consistency, bioactivity preservation, and application-specific stability.
We utilize deeply desulfurized and deionized high-purity agarose to ensure superior biocompatibility and minimal impurities, meeting stringent requirements for medical-grade applications.
Our advanced microsphere fabrication techniques enable precise control from micron to sub-millimeter scales with narrow size distribution, supporting diverse application scenarios including injection, separation, and drug loading.
Optimized crosslinking density and pore architecture ensure excellent mechanical, thermal, and swelling stability of agarose microspheres under complex operational environments.
We offer multiple surface modification options such as carboxylation, amination, and active group introduction to facilitate subsequent conjugation of drugs, proteins, or cells.
With high surface area and hydrophilic porous structure, our microspheres efficiently encapsulate a broad range of active agents and support sustained or stimuli-responsive release profiles.
Our aseptic processing and endotoxin-free control systems are tailored for injectable-grade applications, and our microspheres are compatible with prefilled delivery systems to support streamlined product integration.
We ensure seamless scale-up from gram-level R&D to kilogram-level manufacturing with standardized protocols, providing high reproducibility and consistent product quality across batches.
Our interdisciplinary team of material scientists and bioengineers provides end-to-end technical assistance, from formulation design and process development to performance validation.
BOC Sciences offers formulation and manufacturing solutions for agarose microspheres specifically designed for diverse applications in aesthetic and regenerative medicine. With our strong foundation in material engineering and biomaterial processing, we categorize agarose microspheres into four functional types. Each class is tailored to meet targeted therapeutic and cosmetic needs, ensuring optimal performance, stability, and safety in medical use.
Primarily used for facial contouring via injection into areas such as the nasal dorsum, nasolabial folds, chin, and jawline. These microspheres deliver structural support and long-lasting volume enhancement. Due to their excellent mechanical integrity and injectability, they can be used alone or in combination with hyaluronic acid to achieve natural, stable, and extended aesthetic effects.
Designed for embedding anti-aging agents such as peptides, vitamins, and coenzyme Q10. These porous, surface-functionalizable microspheres enable controlled release of active substances, helping improve skin elasticity, reduce pigmentation, and stimulate collagen regeneration. Their compatibility with various bioactive ingredients supports advanced skincare and injectable formulations.
Functioning as carriers for cells or growth factors, these microspheres are applied in tissue regeneration scenarios such as cartilage repair, periodontal reconstruction, and hair follicle regeneration. With superior cell adhesion properties and full biodegradability, they act as injectable scaffolds in regenerative medicine to support tissue integration and repair.
Integrated with hydrogel matrices, these microspheres are suited for applications in chronic wound healing, acne treatment, and postoperative skin repair. They maintain a moist healing environment and promote tissue regeneration, while also serving as delivery systems for anti-inflammatory or antimicrobial agents to enhance therapeutic outcomes.
BOC Sciences offers a variety of cutting-edge agarose microsphere preparation methods, each designed to meet specific application needs. These advanced techniques allow for precise control over particle size, morphology, and mechanical properties, ensuring high performance and reliability in aesthetic and biomedical products. Below are the key methods we employ for agarose microsphere development:
Membrane emulsification is a crucial method for producing uniform, high-purity agarose microspheres. By mixing an agarose solution with an oil phase and utilizing a hydrophobic SPG membrane under high-pressure conditions, this technique creates microspheres with an average diameter of around 30μM, a porosity of 0.62, and a CV value of 25%. This method also enables further crosslinking of agarose microspheres, enhancing their mechanical strength and stability.
Pre-crosslinking involves introducing crosslinking agents (such as allyl glycidyl ether) into the agarose solution before microsphere formation. This process significantly improves the mechanical strength and porosity of the microspheres while maintaining a small particle size, making it ideal for creating microspheres with enhanced structural integrity.
Microfluidic technology utilizes microchannels to precisely generate agarose microspheres, allowing for exact control of particle size and shape. By adjusting operating temperatures and agarose concentrations, microspheres can be produced with diameters ranging from 20μM to 130μM, offering flexibility for different applications.
The fluidic titration method uses Dolomite droplet chips to generate agarose microspheres efficiently and reproducibly. This technique ensures consistent particle formation and high repeatability, making it suitable for large-scale production.
Suspension stirring and spray drying are traditional methods for preparing agarose microspheres. These processes involve dissolving agarose in water, adding an oil phase, and stirring to form an emulsion, followed by spray drying to produce the final microspheres.
Gelation technology involves cooling the agarose solution below its gelation point to solidify it into microspheres. The microspheres are then freeze-dried to remove water, resulting in the final product with enhanced stability and structural integrity.
BOC Sciences offers customized agarose microsphere modification services focused on enhancing performance and adaptability for aesthetic materials. Through techniques such as crosslinking, PEG modification, surface functionalization, and bioactive compound incorporation, we significantly improve the mechanical strength, biocompatibility, and controlled release properties of the microspheres. We can precisely control particle size (20–200μM), porosity, and surface charge to meet specific material requirements. Modified agarose microspheres offer excellent dispersion, structural stability, and functional versatility, making them ideal for developing a wide range of cosmetic products, such as shaping materials, drug delivery systems, and skin support materials. BOC Sciences provides comprehensive technical support from material design to application validation, backed by a rigorous quality control system and scalable production capabilities.
BOC Sciences offers a comprehensive testing platform for the development and optimization of agarose microspheres, specifically designed for applications in aesthetic medicine and biomedical fields. Our platform utilizes a wide range of advanced testing methods and equipment to thoroughly assess the key characteristics of agarose microspheres. These include physicochemical properties, surface modifications, biocompatibility, drug delivery capabilities, and overall performance. With our state-of-the-art testing platform, we provide robust support for the development of microsphere-based systems for cosmetic and therapeutic applications.
Agarose, a highly purified natural polysaccharide, is extensively used in both biomedical and cosmetic industries due to its exceptional gelling ability, biocompatibility, and structural versatility. Its unique physical and biological properties allow for a wide range of medical and aesthetic applications, particularly in regenerative medicine, wound healing, and facial rejuvenation.
Agarose microspheres are widely used in aesthetic medicine for facial fillers, skin regeneration scaffolds, and sustained-release injectables. Their natural polysaccharide composition offers excellent biocompatibility and biodegradability, minimizing adverse reactions and enhancing patient comfort.
Compared to hyaluronic acid and poly-L-lactic acid (PLLA), agarose microspheres provide stronger structural support and better shape retention. They have lower water absorption and longer-lasting effects, and their tunable structure allows for customizable firmness and tissue integration.
Agarose is derived from natural seaweed and exhibits high biocompatibility with minimal immunogenicity. With proper purification and sterilization, agarose microspheres show a very low incidence of inflammation or post-procedure complications, making them a safe alternative for cosmetic injectables.
By adjusting the crosslinking density, particle size, and surface functionalities, agarose microspheres can be tailored for specific applications such as under-eye hollows, nasolabial folds, chin contouring, or mid-face volume restoration, offering precise control over texture, longevity, and integration with skin tissue.
The market outlook for agarose microspheres in aesthetic medicine is optimistic, driven by rising demand for biocompatible, tunable, and naturally derived materials. Their structural versatility and formulation adaptability make them a competitive option for developing differentiated, next-generation aesthetic products.